The feasibility of obtaining oncotype DX breast recurrence score® results from metastatic sites of patients with hormone receptor positive metastatic breast cancer

被引：0
|
作者：
Gemmill, Julie Anne L. [1 ]
Thompson, Patricia [1 ]
Batiste, Rebecca [1 ]
Vacchi-Suzzi, Caterina [1 ]
Preece, Christina [1 ]
Cohen, Jules [1 ]
Baer, Lea [1 ]
Mies, Carolyn [2 ]
Turner, Michelle [2 ]
Russell, Christy A. [2 ]
Stopeck, Alison [1 ]
机构：
[1] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[2] Genom Hlth Inc, Redwood City, CA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS5-37
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Breast cancer specific survival in patients with node-positive hormone receptor positive invasive breast cancer and Oncotype DX recurrence score results in the SEER database
    Roberts, Megan
    Petkov, Valentina I.
    Miller, Dave P.
    Shak, Steven
    Howlader, Nadia
    Cronin, Kathleen
    Penberthy, Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
    Joshua A. Bloom
    Yurie Sekigami
    Rebekah Young
    Lisa Macera
    Christy A. Russell
    Yu Cao
    Rachel J. Buchsbaum
    Stephen P. Naber
    Abhishek Chatterjee
    Annals of Surgical Oncology, 2021, 28 : 8711 - 8716
  • [3] Discordance in Oncotype DX Breast Recurrence Score Results for Bilateral Breast Cancer
    Bloom, J. A.
    Sekigami, Y.
    Cao, Y.
    Buchsbaum, R. J.
    Naber, S. P.
    Chatterjee, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S51 - S51
  • [4] The effect of Oncotype DX® Recurrence Score on treatment recommendations for geriatric patients with early stage hormone receptor positive breast cancer
    Loftus, L.
    Acs, G.
    Kiluk, J.
    Laronga, C.
    Lee, M. C.
    Soliman, H.
    Boughey, J. C.
    Acs, P.
    Gordon, L.
    Sokol, G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S33 - S34
  • [5] Discordance in Oncotype DX Breast Recurrence Score(R) Results for Bilateral Breast Cancer
    Bloom, Joshua A.
    Sekigami, Yurie
    Young, Rebekah
    Macera, Lisa
    Russell, Christy A.
    Cao, Yu
    Buchsbaum, Rachel J.
    Naber, Stephen P.
    Chatterjee, Abhishek
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) : 8711 - 8716
  • [6] Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
    Fried, Georgeta
    Moskovitz, Mor
    SPRINGERPLUS, 2014, 3 : 1 - 8
  • [7] Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
    Megan C. Roberts
    Dave P. Miller
    Steven Shak
    Valentina I. Petkov
    Breast Cancer Research and Treatment, 2017, 163 : 303 - 310
  • [8] Utilization and survival benefit of radiation therapy among hormone receptor positive breast cancer patients with recurrence score from Oncotype DX testing
    Zhang, L.
    Hsieh, M-C
    Petkov, V. I.
    Wu, X-C
    Yu, Q.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
    Roberts, Megan C.
    Miller, Dave P.
    Shak, Steven
    Petkov, Valentina I.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (02) : 303 - 310
  • [10] Breast cancer specific mortality in patients with early-stage hormone receptor-positive invasive breast cancer and oncotype DX recurrence score results in the SEER database.
    Shak, Steven
    Petkov, Valentina
    Miller, Dave P.
    Howlader, Nadia
    Gliner, Nathan
    Howe, Will
    Schussler, Nicola C.
    Cronin, Kathleen
    Baehner, Frederick L.
    Penberthy, Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
12345